Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 2759 for:    Neuroendocrine Tumors | Neuroendocrine Tumors

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03197012
Recruitment Status : Recruiting
First Posted : June 23, 2017
Last Update Posted : August 1, 2017
Sponsor:
Information provided by (Responsible Party):
Thomas Hope, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 1, 2020
  Estimated Study Completion Date : July 1, 2021